# POTEN-C (NCT03525262)

> Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: localized prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03525262
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: University of Texas Southwestern Medical Center
- Conditions: Prostate Cancer Adenocarcinoma
- Interventions: 30Gy (Gray) planning target volume (PTV)
- Enrollment: 124
- Primary outcome: To compare the decline in patient health-related quality of life.

## Indexed commentary on POTEN-C so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 10

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=poten-c-nct03525262

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03525262", "email": "<work email>"}; the inbox owner confirms by the emailed link.